ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2345

Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain

Rabih Nayfe1, Emily Bowen2, Nathaniel Milburn2, Helen Mayo2, Ethan Halm2, MC. Reid3, Liana Fraenkel4 and Una E. Makris5, 1Department of Medicine, UT Southwestern Medical Center, Dallas, TX, 2UT Southwestern Medical Center, Dallas, TX, 3Weill Cornell Medicine, New York, NY, 4Yale University School of Medicine, New Haven, CT, 5UT Southwestern Medical Center and Dallas VA, Dallas, TX

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Chronic pain, Osteoarthritis, patient preferences and surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Patient Outcomes, Preferences, and Attitudes Poster II: Patient Perspectives

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Chronic musculoskeletal (MSK) pain is common and disabling; it is among the top reasons for doctor’s visits in the US. Most treatment decisions for chronic MSK pain are preference-sensitive, meaning that there is more than one reasonable treatment option.  Patient decision aids (PDAs) are tools to help patients participate in their healthcare decisions. We performed a systematic review of PDAs for adults deciding about treatment for chronic MSK pain.

Methods:

We searched Ovid MEDLINE, Ovid MEDLINE In-Process and EPub Ahead of Print, Ovid Embase, Ovid PsycINFO, EBSCO CINAHL, Cochrane CENTRAL, clinicaltrials.gov, and the International Clinical Trials Registry Platform from inception until March 2017. We included randomized controlled trials of adults using PDAs to make treatment decisions for chronic MSK pain in the outpatient setting. We evaluated outcomes related to decision making (knowledge, accurate risk perception, choice congruence with values, decisional conflict, patient-practitioner communication, satisfaction), pain, functional status, and surgery utilization.

Results:

We reviewed a total of 342 abstracts, and 12 met our inclusion criteria.  Five studies evaluated patients with knee osteoarthritis (OA) alone.  Four studies evaluated patients with either hip or knee OA.  Two studies evaluated patients with lower back pain.  One study evaluated patients with knee pain, back pain, knee or hip OA.

In one study, patients used the PDA to decide between conservative management options for chronic lower back pain.  This was the only study that evaluated pain and function outcomes.  There was less improvement in one disability score but otherwise no difference with the PDA compared to control.

In the other 11 studies, patients were deciding between surgical and medical management using a video PDA.  Seven of eight studies found no difference in the proportion of patients choosing surgery.  The effects of the PDAs on decision-related outcomes were mixed.  Six of seven studies found improved knowledge scores with use of a PDA.  Two of five studies found an improvement in decisional conflict with use of a PDA.  The addition of motivational interviewing, an adaptive conjoint analysis tool, or telephone based health coaching to a PDA did not improve any of the outcomes compared to the use of the PDA alone. Characteristics of included studies and selected outcomes are reported in the table.

Conclusion:

PDAs may improve the decision-making process and decision quality for patients deciding between operative and medical management of hip/knee OA and chronic back pain. Additional research is needed to evaluate the effect of PDAs on pain and function. Especially for older adults with multi-morbidity and polypharmacy, who are often not surgical candidates, further research should develop PDAs for non-surgical treatment of chronic MSK pain.


Disclosure: R. Nayfe, None; E. Bowen, None; N. Milburn, None; H. Mayo, None; E. Halm, None; M. Reid, None; L. Fraenkel, None; U. E. Makris, None.

To cite this abstract in AMA style:

Nayfe R, Bowen E, Milburn N, Mayo H, Halm E, Reid M, Fraenkel L, Makris UE. Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/systematic-review-of-patient-decision-aids-for-chronic-musculoskeletal-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systematic-review-of-patient-decision-aids-for-chronic-musculoskeletal-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology